The effects of hypoglycemia on regional cere bral blood flow (rCBF) were studied in awake restrained rats. The rats were divided into three groups consisting of (1) a normoglycemic control group that received only sa line, (2) a hypoglycemic group A, which was given insulin 30 min before flow was measured, and (3) a hypo glycemic group B, which was given insulin 90 and 30 min before flow was measured. Regional CBF was measured using 14C-iodoantipyrine. Mean plasma glucose was 8.76 f.Lmollml in the control group, 2.63 f.Lmollml in hypogly cemic group A, and 1.5 1 f.Lmollml in hypoglycemic group B. Plasma epinephrine and norepinephrine concentra tions increased to approximately 375% and 160%, respec tively, of control values in hypoglycemic groups A and B.
Summary:
The effects of hypoglycemia on regional cere bral blood flow (rCBF) were studied in awake restrained rats. The rats were divided into three groups consisting of (1) a normoglycemic control group that received only sa line, (2) a hypoglycemic group A, which was given insulin 30 min before flow was measured, and (3) a hypo glycemic group B, which was given insulin 90 and 30 min before flow was measured. Regional CBF was measured using 14C-iodoantipyrine. Mean plasma glucose was 8.76 f.Lmollml in the control group, 2.63 f.Lmollml in hypogly cemic group A, and 1.5 1 f.Lmollml in hypoglycemic group B. Plasma epinephrine and norepinephrine concentra tions increased to approximately 375% and 160%, respec tively, of control values in hypoglycemic groups A and B.
Insulin-induced hypoglycemia has been an im portant model in the study of cerebral energy me tabolism (Siesjo, 1978) . It has been used as a means to study carbohydrate metabolism in brain, alter nate substrates for cerebral energy metabolism, and the pathophysiology of coma. However, during the course of these studies, there has been disagree ment as to the effects of hypoglycemia on cerebral blood flow (CBF). Some studies have reported that hypoglycemia had no effect on CBF, even when hypoglycemia was severe enough to produce coma (Kety et aI., 1948; Eisenberg and Seltzer, 1962; Ghajar et aI., 1982) , whereas other studies have re ported that CBF increased prior to or during hy-In the hypoglycemic group A, rCBF significantly in creased in three brain regions. In the hypoglycemic group B, rCBF increased signficantly in all brain regions mea sured, with the exception of the neural lobe, in which it decreased. The increase in rCBF ranged from 38% in the hypothalamus to 138% in the thalamus. Neural lobe blood flow significantly decreased by 31%. The neural lobe was the only brain region studied that is not pro tected by a blood-brain barrier. It may be sensitive to changes in the concentration of vasoactive agents in blood, such as epinephrine and norepinephrine. Key Words: Cerebral blood flow-Hypoglycemia-Rats Neural lobe blood flow-Insulin-induced hypoglycemia -Iodoantipyrine.
poglycemic coma (Della Porta et aI., 1964; Norberg and Siesjo, 1976; Abdul-Rahman et aI., 1980) . Two studies in neonates reported that CBF did not change during hypoglycemia (Gardiner, 1980; Her nandez et aI., 1980) . The reason for the discordant results may be due to differences in species used in the studies, the presence or absence of anesthesia in the experimental animals, or the nutritional state of the animals.
In an attempt to resolve the discrepancy, Ghajar et ai. (1982) studied CBF in awake rats (i.e., free of anesthesia). The authors reported that hypogly cemia had no effect on blood flow measured in two cortical regions. CBF in other brain regions was not measured.
In another study, Abdul-Rahman et aI. (1980) measured regional CBF (rCBF) in rats that were paralyzed and artificially ventilated with nitrous oxide/oxygen. The authors reported that individual brain regions were affected differently by insulin induced hypoglycemia. When blood glucose de creased from the normal level of 6 fLmol/ml to 1.26 fLmollml (corresponding to 8.4 and 1.76 fLmollml plasma glucose), rCBF significantly increased in all brain regions studied. The increases ranged from 1.4 to 3.2 times the flow in normoglycemic control rats. When blood glucose decreased to 0.73 f.Lmol/ ml (1 f.Lmol/ml plasma glucose) (corresponding to cessation of EEG activity), rCBF in some struc tures further increased to 4-5 times that of the con trol rats. Studies from the same laboratory reported that interpretation of the results was confounded by the animal model used in the studies (Siesjo et aI., 1983) . Rats that are paralyzed and ventilated with nitrous oxide have an elevated mean arterial blood pressure (MABP) (Siesjo et ai., 1983) . During hypo glycemia, autoregulation was lost in some brain re gions, partially lost in others, and preserved in still other regions (Siesjo et a!., 1983) . Those regions in which autoregulation was lost or partially lost had rates of flow that were affected by the elevated MABP.
In this article, we report rates for rCBF during insulin-induced hypoglycemia in awake rats. MABP is not elevated in awake rats during hypo glycemia and thus, would not be responsible for increasing rCBF. Regional CBF increased in every brain region measured when plasma glucose fell below 2-2.5 f.Lmol/ml, with the exception of the neural lobe of the pituitary, which decreased by approximately 3 1%.
METHODS

General
Experiments were performed on 21 male Long-Evans rats (Charles River, Wilmington, MA, U.S.A.) with a mass between 260 and 370 g. All rats were fasted for 18 h before surgery, but were allowed free access to water.
Animal preparation
Anesthesia was induced with 4% halothane in nitrous oxide/oxygen (70%/30%). After induction, the halothane was reduced to 1.5%. Catheters were placed in the left femoral artery and vein. The surgical wounds were infil trated with lidocaine hydrochloride and closed. A plaster cast was fitted around the lower quarter of each rat to immobilize the hindlimbs and protect the catheters. Body temperature was monitored and maintained at 37°C. An esthesia was discontinued, and each rat was allowed 5 h to recover before rCBF was measured.
Experimental procedure
Rats were divided into a normoglycemic control group and two hypoglycemic groups, which were designated as hypoglycemic groups A and B. The normoglycemic con trol rats received an i. v. injection of saline 90 min and 30 min before rCBF was measured. The hypoglycemic group A received i. v. saline 90 min before rCBF was measured and insulin at 15 U/kg body weight 30 min be fore rCBF was measured. The hypoglycemic group B re ceived insulin at 15 U/kg body weight, i. v., 90 min before rCBF was measured and an additional 5 U/kg body weight, i.v., 30 min before rCBF was measured. Immediately before the rCBF measurement, hematocrit, heart rate, and MABP were measured, and arterial blood samples were withdrawn from the femoral artery for the determination of blood gasses and pHa, plasma glucose, and plasma catecholamines. Plasma glucose was mea sured using a Beckman Glucose Analyzer (Beckman In struments Co., Brea, CA, U.S.A.). Plasma catechol amines (epinephrine and norepinephrine) were measured using a radioenzymatic assay described by Peuler and Johnson (1977) .
Measurement of rCBF
Regional CBF was measured using the diffusible indi cator, 4-iodo-(N-methyl-14C) antipyrine (lAP) (Sakurada et aI., 1978) . Approximately 40 j-lCi lAP in 0.7 ml of phys iological saline was infused into the femoral vein catheter over 30 s. Nine arterial blood samples were taken at pre determined time intervals during the lAP infusion by al lowing blood to drip into tubes from the arterial catheter (approximately 5 cm). Thirty seconds after beginning the lAP infusion, each rat was killed by decapitation. After death, the brain was rapidly removed and dissected. Tissue samples from 17 brain regions were weighed, solu bilized, and counted in a liquid scintillation counter. The pituitary was immediately frozen in liquid Freon and placed in a freezer at -70°C. Each pituitary was cut into 20-j-lm thick sections with a cryostat (AO Reichart, Buf falo, NY, U.S.A.). Representative sections were placed on glass slides and dried at 50°C. The glass slides con taining the pituitary sections were packed with 14C_ methyl methacrylate standards (Amersham, Arlington Heights, IL, U.S.A.) in light-tight cassettes for the au toradiographic determination of the tracer in the neural lobe. The tracer concentration was determined by com paring the optical densities of the neural lobe images to the optical densities produced by the calibrated standards (Reivich et aI., 1969 ). An aliquot from each blood sample was solubilized, decolorized, and counted in a liquid scintillation counter. Regional CBF was calculated by the method of Sakurada et al. (1978) , using a brain-to-blood partition coefficient of 0.8 for all regions.
Statistical analysis
For physiological parameters, the significance of dif ferences between means of the hypoglycemic groups and the normoglycemic control group was determined using the t test for pooled samples, with a Bonferroni correc tion for multiple comparisons. The rates of rCBF were logarithmically transformed and analyzed by repeated measures analysis of variance (Winer, 1971) , using the SAS General Linear Models Analysis. The acceptable level of significance was 5% (p < 0.05).
RESULTS
All rats were conscious at the time rCBF was measured. Some of the hypoglycemic rats, espe cially those in group B, showed depressed motor activity, but responded to tactile stimulation. Many of the rats in group A could not be distinguished by observing their behavior from the rats in the nor moglycemic control group.
Mean plasma glucose was 8.76 f.Lmol/ml in the normoglycemic control group, 2.63 f.Lmol/ml in the hypoglycemic group A, and 1.5 1 fLmollml in hypo glycemic group B (Table 1) . MABP decreased in hypoglycemic group A, but was not significantly different from control in hypoglycemic group B. P aco2 increased and pHa decreased from the con trol values in both of the hypoglycemic groups. Plasma epinephrine and norepinephrine concentra tions increased to approximately 375% and 160%, respectively, of the control levels in both hypogly cemic groups.
Mean rates of rCBF in the three groups are shown in Table 2 . Regional CBF in hypoglycemic group A increased in all brain regions measured, with the exception of the neural lobe. Twelve of the 18 regions measured showed a statistically signifi cant increase in rCBF compared to the normogly cemic control group. In the hypoglycemic group B, rCBF in all regions measured increased signifi cantly compared to the normoglycemic controls, with the exception of the neural lobe, in which it significantly decreased. Regional CBF in the hy poglycemic group B was significantly greater in 14 regions compared to hypoglycemic group A. Table 3 shows rates for rCBF in the normogly cemic control group and the two hypoglycemic groups after rCBF was corrected for changes in P aco2' The correction assumed a 5% increase in rCBF for each mm Hg that Paco2 increased (Her nandez et aI. , 1978). Nilsson et al. (1981) demon strated that although autoregulation was lost during hypoglycemia, the CO2 response of the circulation was retained. After correcting for Paco2, only the olfactory bulb, caudate-putamen, and thalamus showed a significant increase in rCBF for hypogly cemic group A when compared to the normogly cemic control group. In hypoglycemic group B, rCBF was significantly greater in all regions com pared to the normoglycemic controls, with the ex ception the neural lobe. Regional CBF was signifi cantly greater in 13 brain regions in hypoglycemic group B compared to hypoglycemic group A.
The neural lobe was not corrected for changes in Paco2 in the hypoglycemic groups and is not in cluded in Table 3 , as the correction factor for the neural lobe may be different than in other brain re gions (Page et aI. , 1981) and is not known for the rat. However, the decrease in blood flow in the neural lobe would be accentuated rather than di minished after correcting for altered Paco2 (see Dis cussion). Figure 1 shows rCBF, corrected for Paco2, in the two hypoglycemic groups as a percent of rCBF in the normoglycemic controls. As the neural lobe was not corrected for Paco2, it is shown separately in Fig. 2 . As demonstrated by the bar graphs, hypo glycemia affected different brain regions to dif ferent degrees. In hypoglycemic group B (dark bars), the thalamus showed the greatest increase (238% of control), and the hypothalamus showed the least increase (138% of control). Neural lobe blood flow in hypoglycemic groups A and B was 85% and 69% of the normoglycemic controls, re spectively.
A plot of rCBF (corrected for Paco2) as a func tion of plasma glucose is shown in Fig. 3 for four representative brain regions. The circles represent individual rates of rCBF for rats in the normogly cemic control group, the squares represent indi vidual rates for rats in hypoglycemic group A, and the diamonds represent individual rates for rats in hypoglycemic group B. Regional CBF increased in all brain regions, with the exception of the neu ral lobe, when plasma glucose fell below 2-2.5 fLmollml.
DISCUSSION
Our results show that rCBF increased during hy poglycemia in all brain regions, with the exception of the neural lobe. The increase was greater than could be explained by changes in Paco2 alone. Fur thermore, a loss of autoregulation could not be re- Physiological values for each group are given in Table I . Regional CBF has not been corrected for changes in Paco, in the hypoglycemic groups, a p < 0,05 compared to normoglycemic rats, b p < 0.01 compared to normoglycemic rats.
e p < 0,05 hypoglycemic group B compared to hypoglycemic group A, d P < 0.01 hypoglycemic group B compared to hypoglycemic group A.
sponsible for the increase in rCBF during hypogly cemia, as MABP in the normoglycemic controls and the hypoglycemic group B was not different. The effect of hypoglycemia on rCBF varied de pending on the brain region. In hypoglycemic group B, rCBF in the hypothalamus increased to 138% of control and rCBF in the thalamus increased to 238%. Other brain regions showed an increase in rCBF that ranged between the hypothalamus and thalamus (see Fig. 1 ). Our results agree with the earlier results of Abdul-Rahman et al. (1980) , who measured rCBF in anesthetized, paralyzed, and artificially venti lated rats. Both studies found that rCBF increased before the onset of coma and that the increase was not uniform, but rather varied among brain regions. Abdul-Rahman et al. (1980) reported that the eleva tion in rCBF persisted during coma, with an addi tional increase in blood flow in some brain regions.
U sing a venous outflow method for measuring CBF, Nilsson et al. (1981) showed that autoregula tion was lost during hypoglycemia. Siesjo et al. (1983) furthered this study by showing that during hypoglycemia, autoregulation was lost in some brain regions, partially lost in others, and preserved in still other brain regions. In the study by Abdul Rahman et al. (1980) , rCBF in some brain regions was affected during hypoglycemia by an elevated MABP of their animal model. However, Siesjo et (1983) showed that even when MABP was con trolled during hypoglycemic coma by bleeding the rats, rCBF increased significantly in 16 of the 24 brain regions studied. Three brain regions (parietal, auditory, and cingulate cortices) showed a signifi cant decrease in rCBF when MABP was prevented from increasing. Comparison of our study to that reported by Siesjo et al. (1983) is not practical, as the two studies looked at different levels of hypo glycemia, and we did not measure as many brain regions as Siesjo et al. (1983) . There has been only one previous study where CBF was measured during hypoglycemia in awake rats (Ghajar et al., 1982) . Contrary to our results, these authors reported that CBF did not change during hypoglycemia at plasma glucose levels com parable to those in our study. Furthermore, Ghajar et al. (1982) found that CBF did not change even after the cessation of EEG activity. However, there were several differences between the two studies. First, the strain and sex of the rats were different in the two studies. Second, Ghajar et al. (1982) mea sured CBF in the frontal and parieto-occipital cor tices using a 14C-butanol indicator-fractionation technique, whereas we used 14C-iodoantipyrine. Third, although rats in our study were restrained by plaster casts fitted around the groin and hip area, Ghajar et al. (1982) Regional CBF has been corrected to 38.5 mm Hg for P aCo2 (mean P aC02 for normoglycemic controls) using a correction of 5% change in rCBF for each mm Hg (Hernandez et aI., 1978) . Error bars = 1 SE; *p < 0.05 compared to normoglycemic rats; **p < 0.01 compared to normoglycemic rats; #p < 0.05 hypoglycemic group B compared to hypoglycemic group A; up < 0.01 hypoglycemic group B compared to hypoglycemic group A. by securing the nose between a bar and nose brace.
Other than the possibility of the differences noted above, we have no explanation as to the different effects of hypoglycemia on CBF in the two studies.
Previous work from this laboratory demonstrated that 2-2.5 f.Lmol/ml is a critical level for plasma glu cose. Below this level, regional cerebral glucose utilization decreased (Bryan et aI., 1986) , other substrates were utilized as a source of energy (Bryan and Jobsis, 1986) , and the respiratory chain became oxidized due to a decrease in reducing equivalents from glucose Jobsis, 1983, 1986) . In the present study, we have demonstrated that rCBF increased in all brain regions, except the neural lobe, when plasma glucose values fell below 2-2.5 f.Lmol/ml (Fig. 3) . Perhaps the increase in rCBF during hypoglycemia was an attempt to maintain the glucose supply to the brain when plasma glucose decreased below this critical level.
Studies in anesthetized sheep indicate that the neural lobe and median eminence are not as sensi tive to changes in Paco2 as other brain regions are (Page et aI., 1981) . Blood flow in sheep brain in creased 4% for each mm Hg that Paco2 increased, except for the neural lobe and median eminence, where blood flow increased by 1.5 %/mm Hg for Paco2 values below 40 mm Hg. Above 40 mm Hg,
